Ajou University repository

Frontiers in Immunology
ISSN
  • E1664-3224
Publisher

Frontiers Media S.A.

Listed on
(Coverage)

JCR2015-2023

SJR2011-2020;2022-2023

CiteScore2011-2023

SCIE2015-2024

SCOPUS2017-2024

MEDLINE2018-2024

DOAJ2017-2024

EMBASE2016-2024

OA Info.
OA oa mark

based on the information

  • 2017;2018;2019;2020;2021;2022;2023;2024;2025;
Keywords immunology, adaptive immunity, innate immunity, clinical immunology, molecular immunology
Review Process Anonymous peer review
Journal info.
pages
Licences CC BY
Copyrights Yes
DOAJ Coverage Added on Date : 2011-04-28T15:54:40Z
Subject(s) Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Active
Active

based on the information

  • SCOPUS:2024-10
Country
SWITZERLAND
Aime & Scopes
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Further, the availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology portrays how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treat immune disorders, both in animal and cellular models and in humans. All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals. Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.
Article List

Showing results 1 to 8 of 8

Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencingoa mark
  • An, Seungchan;
  • Zheng, Mei;
  • Park, In Guk;
  • Park, Sang Gyu;
  • Noh, Minsoo;
  • Sung, Jong Hyuk
  • 2024-01-01
  • Frontiers in Immunology, Vol.15
  • Frontiers Media SA
Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacyoa mark
  • 2022-10-27
  • Frontiers in Immunology, Vol.13
  • Frontiers Media S.A.
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variantsoa mark
  • Lee, Sua;
  • Jang, Shina;
  • Kang, Jihoon;
  • Park, Soo Bin;
  • Han, Young Woo;
  • Nam, Hyemi;
  • Kim, Munkyung;
  • Lee, Jeewon;
  • Cho, Ki Joon;
  • Kim, Jeonghun;
et al
  • 2021-11-18
  • Frontiers in Immunology, Vol.12
  • Frontiers Media S.A.
Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulationoa mark
  • Kim, Young In;
  • Yi, Eun Je;
  • Kim, Young Dae;
  • Lee, A. Reum;
  • Chung, Jiwoung;
  • Ha, Hae Chan;
  • Cho, Joong Myung;
  • Kim, Seong Ryeol;
  • Ko, Hyun Jeong;
  • Cheon, Jae Hee;
et al
  • 2021-01-14
  • Frontiers in Immunology, Vol.11
  • Frontiers Media S.A.
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicityoa mark
  • Kim, Jung Eun;
  • Lee, Dong Hyun;
  • Jung, Keunok;
  • Kim, Eun Ji;
  • Choi, Youngwoo;
  • Park, Hae Sim;
  • Kim, Yong Sung
  • 2021-01-08
  • Frontiers in Immunology, Vol.11
  • Frontiers Media S.A.
Salmonella Typhimurium Lacking YjeK as a Candidate Live Attenuated Vaccine Against Invasive Salmonella Infectionoa mark
  • Park, Soyeon;
  • Jung, Bogyo;
  • Kim, Eunsuk;
  • Hong, Seong Tshool;
  • Yoon, Hyunjin;
  • Hahn, Tae Wook
  • 2020-06-23
  • Frontiers in Immunology, Vol.11
  • Frontiers Media S.A.
B cell-based vaccine transduced with esat6-expressing vaccinia virus and presenting α-galactosylceramide is a novel vaccine candidate against esat6-expressing mycobacterial diseasesoa mark
  • Kwon, Bo Eun;
  • Ahn, Jae Hee;
  • Park, Eun Kyoung;
  • Jeong, Hyunjin;
  • Lee, Hyo Ji;
  • Jung, Yu Jin;
  • Shin, Sung Jae;
  • Jeong, Hye Sook;
  • Yoo, Jung Sik;
  • Shin, Eunkyoung;
et al
  • 2019-01-01
  • Frontiers in Immunology, Vol.10
  • Frontiers Media S.A.
ERDj5 in innate immune cells is a crucial factor for the mucosal adjuvanticity of cholera toxinoa mark
  • 2019-01-01
  • Frontiers in Immunology, Vol.10
  • Frontiers Media S.A.
1